Search Results
Jun 26, 2026, 09:42 ET Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
indicated by forward-looking statements include the factors set forth under the captions "Risk Factor Summary" and "Risk Factors" in our most recent Form 10-K, and the factors that are discussed in other filings that Curis periodically makes with the Securities and Exchange Commission. In addition, any
More news about: Curis, Inc.
Jun 26, 2026, 09:30 ET A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
proprietary NSAs as synthetic molecules designed to activate serotonin pathways that are believed to promote neuroplasticity — the brain's capacity to form new neural connections — with the aim of delivering durable improvements rather than the symptom-by-symptom maintenance of traditional antidepressants.
More news about: USA News Group
Jun 26, 2026, 09:29 ET Air Products Publishes 2026 Sustainability Report
projections and estimates expressed in the forward-looking statements because of many factors, including the risk factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025 and other factors disclosed in our filings with the Securities and Exchange Commission. Except as
More news about: Air Products
Jun 26, 2026, 09:10 ET Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
those factors set forth in "Item 1A - Risk Factors" and other sections of our most recent Annual Report on Form 10-K as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result
More news about: Anixa Biosciences, Inc.
Jun 26, 2026, 09:01 ET Nippon Shinyaku and Elixirgen Therapeutics Enter Option Agreement for Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy
the United States, NS Pharma intends to commercialize EXG-7001.About Duchenne Muscular Dystrophy (Duchenne/DMD)Duchenne is a form of muscular dystrophy that occurs primarily in males. It causes progressive weakness and loss of skeletal, cardiac, and respiratory muscles. Early signs
More news about: NS Pharma, Inc.
Jun 26, 2026, 09:00 ET Securitize and Cantor Equity Partners II Business Combination Expected to Raise Approximately $400 million in Gross Proceeds and Announce Expected Closing of Business Combination and NYSE Listing
Proposed Business Combination, including a copy of the business combination agreement, is available in the Current Report on Form 8-K filed by CEPT, and in the registration statement on Form S-4 filed by Securitize and Securitize Holdings, Inc. ("Pubco") with the U.S. Securities and Exchange Commission (the
More news about: Securitize
Jun 26, 2026, 09:00 ET Finance and AI Executive Patrick Fleury to Join Corvex Board of Directors as Company Scales AI Cloud Infrastructure Platform and Prepares to Launch Token Factory
and uncertainties described in the Company's SEC reports, and under the heading "Risk Factors" in its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are available at
More news about: Corvex
Jun 26, 2026, 09:00 ET Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 25, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," Paramount's most recently filed Quarterly Report on Form 10-Q for the quarter
More news about: Paramount Skydance Corporation
Jun 26, 2026, 08:50 ET From the Lab to the Grid: General Fusion Signs a Framework to Bring Fusion Power to Italy
Magnetized Target Fusion Machine," June 22–23, 2026.[3] Spring Valley Acquisition Corp. III, business combination disclosures; SEC Form F-4 declared effective June 12, 2026; definitive proxy statement, June 12, 2026.[4] Enel S.p.A. (Borsa Italiana: ENEL; OTC: ENLAY),
More news about: Equity Insider
Jun 26, 2026, 08:41 ET i-80 Gold Announces Termination of Gold Offtake Agreement
possible failure to receive required permits, approvals and licenses or changes to existing mining licenses.Please see "Risk Factors" in the Form 10-K for the fiscal year ended December 31, 2025 for more information regarding risks pertaining to the Company, which is available on EDGAR at
More news about: i-80 Gold Corp
Jun 26, 2026, 08:39 ET He's Back: Legendary Pool Builder Bryan O'Neal Returns with O'Neal Shiers Aquatics, Partnering with Second-Generation Master Builder Sean Shiers
nationwide expertise brings a depth of technical knowledge and versatility rarely found in a single builder.Together, these two industry legends form the foundation of O'Neal Shiers Aquatics — a true family business built on more than 50 years of combined excellence, generations of hands-on experience,
More news about: O'Neal Shiers Aquatics
Jun 26, 2026, 08:31 ET Allspring Closed-End Funds Declare Monthly Distributions
investment experience during the remainder of the fiscal year and may be subject to change based on tax regulations. Each fund will send shareholders a Form 1099-DIV for the calendar year that will tell shareholders how to report these distributions for federal income tax purposes.For more information
More news about: Allspring Global Investments
Jun 26, 2026, 08:30 ET FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
including those set forth under the caption "Risk Factors" and elsewhere in FibroBiologics' annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. Copies are available on the SEC's website,
More news about: FibroBiologics, Inc.
Jun 26, 2026, 08:30 ET BTC Digital Ltd. Announces Private Placement Financing of up to $28 Million
date. The exercise price and number of shares issuable under the Common Warrant is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.Gross proceeds to the Company are expected to be approximately $7 million. The potential additional
More news about: BTC Digital Ltd.
Jun 26, 2026, 08:01 ET Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2026, and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements contained in this press release
More news about: Aethlon Medical, Inc.
Jun 26, 2026, 08:00 ET Bottini & Bottini, Inc. Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of Tattooed Chef Common Stock
August 4, 2026, in accordance with the instructions set forth in the Claim Form. If you are a member of the Settlement Class and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement but you will nevertheless
More news about: Bottini & Bottini, Inc.
Jun 26, 2026, 08:00 ET Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Oppenheimer Cash Sweep Litigation
the distribution of the Net Settlement Fund, you must submit a Claim Form postmarked or submitted online no later than September 17, 2026. If you are a member of the Class and do not timely submit a valid Claim Form, you will not be eligible to share in the distribution of the Net Settlement
More news about: Robbins Geller Rudman & Dowd LLP
Jun 26, 2026, 08:00 ET National Kidney Foundation Workshop Identifies Major Gaps in Gout Treatment and Chronic Kidney Disease Care
for the millions of people living with both gout and kidney disease.Approximately 9 million Americans live with gout, making it the most common form of inflammatory arthritis in the United States. People with chronic kidney disease face a significantly higher risk because impaired kidney function
More news about: National Kidney Foundation
Jun 26, 2026, 08:00 ET Cineverse Reports Fourth Quarter and Fiscal Year 2026 Results
Cineverse's filings with the Securities and Exchange Commission, including Cineverse's registration statements, quarterly reports on Form 10-Q and annual report on Form 10-K, are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking
More news about: Cineverse Corp.
Jun 26, 2026, 08:00 ET The AI Boom's Biggest Bottleneck Is Creating Billion-Dollar Opportunities
materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the
More news about: OilPrice.com
Jun 26, 2026, 07:16 ET Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking
More news about: Eli Lilly and Company
Jun 26, 2026, 07:07 ET PowerBank Awarded $2,950,000 USD Federal Contract with the US Department of Defense and the Department of the Army for Covered Parking Canopy Solar Project
under "Forward-Looking Statements" and "Risk Factors" in the Company's most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions;
More news about: PowerBank Corporation
Jun 26, 2026, 07:00 ET Catalyst Bancorp, Inc. and Lakeside Bancshares, Inc. Announce Shareholder and Regulatory Approvals for Pending Mergers
mergers; and (vii) other factors which Catalyst discusses or refers to in its reports (such as the Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K) and other subsequent filings with the SEC, which are available on Catalyst's website or at the SEC's website at
More news about: Catalyst Bancorp, Inc.
Jun 26, 2026, 06:01 ET MetaOptics Begins Shipment of Metalens Smartphone and AI Smart Glasses to European and Japanese Customers for Evaluation
incorporate a compact colour metalens camera system, enabling intuitive gesture-based control. Its lightweight, sporty form factor is designed for all-day wearability, all powered by the Qualcomm AR1 Snapdragon platform.Next-Generation Colour Camera ModuleAs
More news about: METAOPTICS LTD
Jun 26, 2026, 04:30 ET AerCap Delivers First of Three New Airbus A321neo Aircraft to Azerbaijan Airlines
included in this press release will prove to be accurate or correct. These and other important factors and risks are discussed in AerCap's annual report on Form 20-F and other filings with the United States Securities and Exchange Commission. In light of these risks, uncertainties and assumptions, the future
More news about: AerCap Holdings N.V.